Scholar

Jeffrey Peppercorn

Videos
H-index: 50
Economics 37%
Biology 32%
more

Reposted by: Jeffrey Peppercorn

jrgralow.bsky.social
Terrific (&entertaining) piece by @jco-asco.bsky.social OP editor @ethicsdoctorp.bsky.social on what he thinks AI could do to transform oncology practice by 2035.

OK Computer! Reflections on How Artificial Intelligence Saved Cancer Care | JCO Oncology Practice ascopubs.org/doi/full/10....
OK Computer! Reflections on How Artificial Intelligence Saved Cancer Care | JCO Oncology Practice
ascopubs.org
2 3

Reposted by: Jeffrey Peppercorn

by Fumiko Chino — Reposted by: Jeffrey Peppercorn

Reposted by: Jeffrey Peppercorn

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Adequacy of Immune Checkpoint Inhibitor–Associated Thyroid Function Monitoring After Therapy | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Adequacy of Immune Checkpoint Inhibitor–Associated Thyroid Function Monitoring After Therapy | JCO Oncology Practice
PURPOSEImmune checkpoint inhibitor (ICI)-induced thyroid dysfunction is a common endocrine immune-related adverse event. Although rates during therapy are well documented, data on post-treatment thyro...
ascopubs.org
1 2

Reposted by: Jeffrey Peppercorn

Reposted by: Jeffrey Peppercorn

Reposted by: Jeffrey Peppercorn

by Jeffrey Peppercorn

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Another great #ASCO25

Also wonderful to see my amazing JCO Oncology Practice colleagues! 📝

Loved Dr. DeMichele’s discussion of SERENA-6 and the incredible CHALLENGE trial data for exercise in colon cancer survivors. 🏃‍♂️

And a chance to hang out for a few hours with my daughter! 🥰
2

Reposted by: Jeffrey Peppercorn

Reposted by: Jeffrey Peppercorn

Reposted by: Jeffrey Peppercorn

Reposted by: Jeffrey Peppercorn

Reposted by: Jeffrey Peppercorn

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Glory Days: Celebrating Two Decades of Advances in Cancer Care on the 20th Anniversary of JCO Oncology Practice | JCO Oncology Practice ascopubs.org/doi/10.1200/...
A fun collaboration and nostolgic review by those fortunate to serve as Editor-in-Chief over the past 20 years. 🥳
2

by Robert S. Miller — Reposted by: Jeffrey Peppercorn

rsm2800.bsky.social
Congrats to ASCO's journal JCO Oncology Practice on your 20-yr anniversary! JCO OP is the unquestioned and authoritative leader on issues of cancer care policy, delivery, & quality ascopubs.org/doi/full/10....
Glory Days: Celebrating Two Decades of Advances in Cancer Care on the 20th Anniversary of JCO Oncology Practice | JCO Oncology Practice
ascopubs.org
1 1 3

Reposted by: Jeffrey Peppercorn

ryannipp.bsky.social
Glory Days: Celebrating Two Decades of Advances in #Cancer Care on the 20th Anniversary of JCO Oncology Practice.

ascopubs.org/doi/full/10....

@ascocancer.bsky.social
#CancerCare #FinancialToxicity #CancerResearch
@ethicsdoctorp.bsky.social @fumikochino.bsky.social @jameabraham.bsky.social
2 5

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | JCO Oncology Practice
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO G...
ascopubs.org
1 4

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Patient, Parent, and Oncologist Perspectives and Recommendations on the Right Way to Talk About Prognosis in Advanced Childhood Cancer | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Patient, Parent, and Oncologist Perspectives and Recommendations on the Right Way to Talk About Prognosis in Advanced Childhood Cancer | JCO Oncology Practice
PURPOSEClear prognostic communication is associated with improvements in quality of life and suffering for children with advanced illness. Yet recent evidence demonstrates that pediatric oncologists o...
ascopubs.org
1

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan | J...
PURPOSEMedicare Part D beneficiaries who do not qualify for low-income subsidies face high out-of-pocket (OOP) costs for brand-name specialty oral anticancer medications (SOAMs). We calculated how OOP...
ascopubs.org

Reposted by: Jeffrey Peppercorn

emiliemgunn.bsky.social
📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here:

SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low–Tumor Burden Follicular Lymphoma | JCO Oncology Advances
ascopubs.org
1 1

Reposted by: Jeffrey Peppercorn

ryannipp.bsky.social
Beyond the Point: Learning From Outcomes After Inpatient Immune Checkpoint Inhibitor Therapy.

ascopubs.org/doi/10.1200/...

@ascopost.bsky.social
@pallonccop.bsky.social
#Immunotherapy #CancerResearch
@ethicsdoctorp.bsky.social
2 3

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice ascopubs.org/doi/10.1200/...
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice
ascopubs.org
1

Reposted by: Jeffrey Peppercorn

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice
ascopubs.org
1 3

Reposted by: Jeffrey Peppercorn

jameabraham.bsky.social
Had a wonderful editorial meeting at @ascocancer.bsky.social headquarters under the leadership of EIC @ethicsdoctorp.bsky.social @acochran12733.bsky.social @fumikochino.bsky.social @ryannipp.bsky.social and others !
1 2 6

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice
Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly discussed the role of ...
ascopubs.org
2

by Jeffrey Peppercorn

ethicsdoctorp.bsky.social
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical Trial | JCO Oncology Practice
PURPOSEGuidelines recommend advance care planning (ACP) to improve patient-centered care near the end of life (EOL), but the optimal approach is unknown. This single-blind, patient-level, randomized c...
ascopubs.org
3

Reposted by: Jeffrey Peppercorn

ryannipp.bsky.social
Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced #Cancer: A Randomized Clinical Trial.

ascopubs.org/doi/10.1200/...

@ascopost.bsky.social
@pallonccop.bsky.social
#PallOnc #SuppOnc #CancerCare
@pittpalcare.bsky.social
4 5

References

Fields & subjects

Updated 1m